T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMT.PRA
926
DELISTED
American Tower Corporation
AMT.PRA
| $38.2M | 0.01% |
376,951
-12,739
| -3% | -$1.32M |
|
|
HAWK
927
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
| $38.1M | 0.01% |
924,642
+54,330
| +6% | +$2.03M |
|
|
LM
928
DELISTED
Legg Mason, Inc.
LM
| $37.8M | 0.01% |
733,710
-272,790
| -27% | -$14.7M |
|
|
ATW
929
DELISTED
Atwood Oceanics
ATW
| $37.8M | 0.01% |
1,427,920
+704,390
| +97% | +$21.6M |
|
930
PennyMac Financial
PFSI
$4.13B
| $37.7M | 0.01% |
2,080,630
+6,200
| +0.3% | +$113K |
|
931
Ventas
VTR
$46.3B
| $37.2M | 0.01% |
525,107
+7,785
| +2% | +$608K |
|
932
Hershey
HSY
$37.4B
| $37.2M | 0.01% |
418,606
+63,500
| +18% | +$5.99M |
|
|
HIBB
933
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $37.1M | 0.01% |
797,395
-142,730
| -15% | -$6.82M |
|
934
Forestar Group
FOR
$1.51B
| $37.1M | 0.01% |
2,816,000
+343,090
| +14% | +$4.95M |
|
|
CSBK
935
DELISTED
Clifton Bancorp Inc.
CSBK
| $36.9M | 0.01% |
2,634,869
+257,950
| +11% | +$3.59M |
|
936
Mueller Water Products
MWA
$3.98B
| $36.9M | 0.01% |
4,050,017
-11,700
| -0.3% | -$113K |
|
|
NLSN
937
DELISTED
Nielsen Holdings plc
NLSN
| $36.6M | 0.01% |
816,525
+103,895
| +15% | +$4.71M |
|
938
Matsons
MATX
$6.39B
| $36.4M | 0.01% |
866,441
-1,200
| -0.1% | -$50.3K |
|
939
Manitowoc
MTW
$753M
| $36.2M | 0.01% |
2,036,265
+21,417
| +1% | +$391K |
|
940
RingCentral
RNG
$5.66B
| $36.1M | 0.01% |
1,953,922
-1,448,399
| -43% | -$25.2M |
|
|
FARO
941
DELISTED
Faro Technologies
FARO
| $36M | 0.01% |
771,800
-124,904
| -14% | -$5.87M |
|
942
Paychex
PAYX
$44.6B
| $36M | 0.01% |
768,691
+40,070
| +5% | +$1.96M |
|
943
Zimmer Biomet
ZBH
$19B
| $36M | 0.01% |
339,484
+16,357
| +5% | +$1.81M |
|
|
CCI.PRA
944
DELISTED
Crown Castle International Corp.
CCI.PRA
| $36M | 0.01% |
352,271
| – | – |
|
945
TherapeuticsMD
TXMD
$24.1M
| $36M | 0.01% |
91,529
+13,586
| +17% | +$4.79M |
|
946
Tyler Technologies
TYL
$13.5B
| $35.9M | 0.01% |
277,800
+10,700
| +4% | +$1.33M |
|
|
NGD
947
DELISTED
New Gold Inc
NGD
| $35.7M | 0.01% |
13,302,470
+2,462,800
| +23% | +$8.06M |
|
948
Compass Diversified
CODI
$924M
| $35.6M | 0.01% |
2,172,878
-60,334
| -3% | -$1.01M |
|
949
Novartis
NVS
$288B
| $35.5M | 0.01% |
403,164
-4,352
| -1% | -$399K |
|
950
Public Service Enterprise Group
PEG
$37.8B
| $35.3M | 0.01% |
899,536
+40,100
| +5% | +$1.66M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.